Maravai LifeSciences Holdings, Inc. (MRVI)
USD 2.07
(-1.43%)
USD 2.07
(-1.43%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 610.96 Million USD | 4.39% |
| 2022 | 585.26 Million USD | 9.54% |
| 2021 | 534.31 Million USD | -9.56% |
| 2020 | 590.78 Million USD | 51.4% |
| 2019 | 390.2 Million USD | 14.8% |
| 2018 | 339.88 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 562.68 Million USD | -7.9% |
| 2024 Q2 | 561.87 Million USD | -0.14% |
| 2023 Q1 | 616.26 Million USD | 5.3% |
| 2023 FY | 610.96 Million USD | 4.39% |
| 2023 Q4 | 610.96 Million USD | -0.6% |
| 2023 Q3 | 614.67 Million USD | -0.42% |
| 2023 Q2 | 617.26 Million USD | 0.16% |
| 2022 Q4 | 585.26 Million USD | 9.58% |
| 2022 Q1 | 529.93 Million USD | -0.82% |
| 2022 FY | 585.26 Million USD | 9.54% |
| 2022 Q2 | 533.4 Million USD | 0.65% |
| 2022 Q3 | 534.09 Million USD | 0.13% |
| 2021 Q3 | 586.9 Million USD | -0.22% |
| 2021 Q1 | 589.51 Million USD | -0.21% |
| 2021 Q4 | 534.31 Million USD | -8.96% |
| 2021 Q2 | 588.2 Million USD | -0.22% |
| 2021 FY | 534.31 Million USD | -9.56% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q3 | 408.14 Million USD | 0.0% |
| 2020 Q4 | 590.78 Million USD | 44.75% |
| 2020 FY | 590.78 Million USD | 51.4% |
| 2019 Q4 | 390.2 Million USD | 0.0% |
| 2019 FY | 390.2 Million USD | 14.8% |
| 2018 FY | 339.88 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -11100.128% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -63016.426% |
| Vaxxinity, Inc. | 15.16 Million USD | -3928.0% |
| IO Biotech, Inc. | 2.49 Million USD | -24397.474% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -9866.835% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -2776.628% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -1705.992% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -339.45% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -67335.651% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -37268.012% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -4129.902% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -604817.822% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -166.295% |
| Agenus Inc. | 350.24 Million USD | -74.439% |
| AlloVir, Inc. | 27.42 Million USD | -2127.449% |
| CRISPR Therapeutics AG | 238.63 Million USD | -156.029% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -166.575% |
| NextCure, Inc. | 6.6 Million USD | -9150.068% |
| Opthea Limited | 200.62 Million USD | -204.526% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -1618.359% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -908.546% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -8598.277% |
| Senti Biosciences, Inc. | 37.66 Million USD | -1522.065% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -486.442% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -203072.117% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 77.225% |
| BioLineRx Ltd. | 11.59 Million USD | -5171.047% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -35154.876% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -4608.439% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -9741.608% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -2389.475% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -1242.49% |
| AbCellera Biologics Inc. | 77.38 Million USD | -689.567% |
| ADMA Biologics, Inc. | 141.41 Million USD | -332.029% |
| Aptorum Group Limited | 3.36 Million USD | -18070.579% |
| AnaptysBio, Inc. | 17.81 Million USD | -3329.701% |
| Ardelyx, Inc. | 55.98 Million USD | -991.363% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -430.487% |
| Bicycle Therapeutics plc | 44.95 Million USD | -1259.033% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -502.627% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -760.808% |
| Clearside Biomedical, Inc. | 43 Million USD | -1320.82% |
| Chimerix, Inc. | 2.14 Million USD | -28396.595% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -2825.494% |
| Dyadic International, Inc. | 136.92 Thousand USD | -446092.552% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1927.299% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -760490.33% |
| Fortress Biotech, Inc. | 88.59 Million USD | -589.641% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -490.101% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -75477.126% |
| Fortress Biotech, Inc. | 88.59 Million USD | -589.641% |
| ChromaDex Corporation | 3.27 Million USD | -18544.095% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -1107426.511% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -2040.664% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -2122.911% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -21173.224% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -190.741% |
| Incyte Corporation | 38.28 Million USD | -1495.756% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -1922.451% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -386587.975% |
| Jaguar Health, Inc. | 35.86 Million USD | -1603.756% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 89.46% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -9810.251% |
| ContextLogic Inc. | 6 Million USD | -10082.783% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -260472.523% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -421.334% |
| MiMedx Group, Inc. | 48.09 Million USD | -1170.228% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -453.623% |
| Structure Therapeutics Inc. | 5.45 Million USD | -11104.234% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -9214.941% |
| Onconetix, Inc. | 9.88 Million USD | -6080.266% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -192027.987% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -7878.782% |
| PDS Biotechnology Corporation | 23.85 Million USD | -2461.533% |
| Precigen, Inc. | 7.09 Million USD | -8508.807% |
| Pharming Group N.V. | 171.54 Million USD | -256.156% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| PureTech Health plc | 25.51 Million USD | -2294.822% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -8746.901% |
| Royalty Pharma plc | 6.13 Billion USD | 90.042% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -2062.026% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -1503.42% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -36861.101% |
| Acelyrin, Inc. | 1.19 Million USD | -51069.765% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -210837.948% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -2764.221% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -135498.385% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -884.24% |
| TG Therapeutics, Inc. | 110.79 Million USD | -451.439% |
| Alkermes plc | 290.73 Million USD | -110.149% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -795.452% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -108035.752% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -36116.183% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -28719.198% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -1802.257% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -6101.451% |
| Geron Corporation | 85.89 Million USD | -611.262% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -3530.226% |
| Summit Therapeutics Inc. | 106.09 Million USD | -475.846% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -8838.8% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -98125.732% |
| Innoviva, Inc. | 449.07 Million USD | -36.05% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -128524.632% |
| Vaxcyte, Inc. | 29.22 Million USD | -1990.634% |
| Molecular Templates, Inc. | 12.23 Million USD | -4895.642% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -285398.598% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -354.237% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -2290.699% |
| Novavax, Inc. | 280.63 Million USD | -117.709% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -3042.026% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -17076.469% |
| Precision BioSciences, Inc. | 31.26 Million USD | -1853.969% |
| GT Biopharma, Inc. | 58 Thousand USD | -1053291.379% |
| ImmuCell Corporation | 11.96 Million USD | -5004.449% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Mesoblast Limited | 118.92 Million USD | -413.75% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -2339.769% |
| Aptose Biosciences Inc. | 1 Million USD | -60403.404% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -7058206.377% |
| Soligenix, Inc. | 3.49 Million USD | -17383.369% |
| Century Therapeutics, Inc. | 48.17 Million USD | -1168.329% |
| Kura Oncology, Inc. | 17.2 Million USD | -3452.134% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -560.984% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -28317.07% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -4272.17% |
| Autolus Therapeutics plc | 52.96 Million USD | -1053.486% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -11071.457% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -1360.141% |
| GRI Bio, Inc. | 14 Thousand USD | -4363950.0% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -4817.635% |
| IGM Biosciences, Inc. | 40.5 Million USD | -1408.337% |
| INmune Bio, Inc. | 10.43 Million USD | -5753.856% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -240.129% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -10242.998% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -747900.735% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -73791.447% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -1080.042% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -948.312% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -955.721% |
| Coherus BioSciences, Inc. | 480.84 Million USD | -27.062% |
| Verastem, Inc. | 41.55 Million USD | -1370.19% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -11214.204% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -5272.555% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -6126.098% |
| Histogen Inc. | 4.62 Million USD | -13118.672% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -17981.296% |
| Organovo Holdings, Inc. | 1.39 Million USD | -43728.336% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -1228.139% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -11662.938% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -2861572.131% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -622.286% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -292200.737% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -1921.998% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -376303.581% |
| Apollomics, Inc. | 4.66 Million USD | -13008.067% |
| Amarin Corporation plc | 8.73 Million USD | -6892.869% |
| Turnstone Biologics Corp. | 3.21 Million USD | -18909.552% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -621.552% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -247255.061% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -525.946% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -221.656% |
| Better Therapeutics, Inc. | 14.88 Million USD | -4005.961% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -1895.711% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -450.778% |
| NLS Pharmaceutics AG | 1.63 Million USD | -37296.694% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -483.123% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -21829.899% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -1250088.255% |
| Avid Bioservices, Inc. | 207.83 Million USD | -193.969% |
| Insmed Incorporated | 1.2 Billion USD | 49.255% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -9003.964% |
| OmniAb, Inc. | 25.56 Million USD | -2290.231% |
| Alector, Inc. | 38.91 Million USD | -1469.883% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -185.584% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -3932.519% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -27.701% |
| Aura Biosciences, Inc. | 19.55 Million USD | -3024.032% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -867.225% |
| Immunic, Inc. | 1.33 Million USD | -45699.625% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -1825.397% |
| Veracyte, Inc. | 12.63 Million USD | -4737.427% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 5.257% |
| FibroGen, Inc. | 170.45 Million USD | -258.433% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -6627.97% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -299524.346% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1651162.162% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -14319.802% |
| Galecto, Inc. | 249 Thousand USD | -245268.273% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -36572.689% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 63.59% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -8249.966% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -11220.493% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -21829.899% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -2172.858% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -1255.506% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -42956.166% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1250.621% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -1315.291% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -1166.804% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 28.013% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -59367.412% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -5477.061% |
| NexImmune, Inc. | 68.8 Thousand USD | -887817.278% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -4304303.269% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 77.396% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -155758.133% |
| Ainos, Inc. | 5.96 Million USD | -10145.012% |
| Pluri Inc. | 29.61 Million USD | -1963.241% |
| Prothena Corporation plc | 11.83 Million USD | -5062.374% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -2321.11% |
| Celularity Inc. | 65.41 Million USD | -833.958% |
| Rallybio Corporation | 392 Thousand USD | -155758.929% |
| Cue Biopharma, Inc. | 14.69 Million USD | -4057.652% |
| MeiraGTx Holdings plc | 89.26 Million USD | -584.449% |
| Omeros Corporation | 338.28 Million USD | -80.609% |
| Humacyte, Inc. | 58.1 Million USD | -951.47% |
| Immunocore Holdings plc | 84.03 Million USD | -627.065% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -32871.775% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -12427.517% |
| Blueprint Medicines Corporation | 774.12 Million USD | 21.076% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -12075.508% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -888.332% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -486.926% |
| Pulmatrix, Inc. | 8.75 Million USD | -6877.695% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -8732.832% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -4311.314% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -429.682% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -1836.626% |
| Cytokinetics, Incorporated | 755.77 Million USD | 19.16% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -4464.906% |
| Nutriband Inc. | 241.28 Thousand USD | -253113.834% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -11075.544% |
| Vor Biopharma Inc. | 35.66 Million USD | -1613.312% |
| Roivant Sciences Ltd. | 499.74 Million USD | -22.255% |
| Evogene Ltd. | 1.13 Million USD | -53587.786% |
| ProKidney Corp. | 4.41 Million USD | -13744.709% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -49734.176% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 64.884% |
| CorMedix Inc. | 667.63 Thousand USD | -91412.54% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -1469.802% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -750.846% |
| Atai Life Sciences N.V. | 16.47 Million USD | -3608.224% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -24827.295% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -90413.63% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -1234.776% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -939849.231% |
| MediciNova, Inc. | 215.92 Thousand USD | -282852.03% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -24387.655% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -48349.915% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -227.821% |
| Biomea Fusion, Inc. | 10.29 Million USD | -5834.023% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -47.212% |
| Mereo BioPharma Group plc | 5.95 Million USD | -10164.903% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -16918.579% |
| Absci Corporation | 15.95 Million USD | -3728.834% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -6569.217% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -4064.454% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -2128.587% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -4884.231% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -4785.391% |
| Allakos Inc. | 41.46 Million USD | -1373.452% |
| Imunon, Inc. | 1.62 Million USD | -37504.588% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -5546.123% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -404513.907% |
| BioAtla, Inc. | 2.46 Million USD | -24736.057% |
| NLS Pharmaceutics AG | 1.63 Million USD | -37296.694% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -540578.761% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -542.305% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -10916.354% |
| XOMA Corporation | 124.45 Million USD | -390.934% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -3126.995% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -1315.357% |
| aTyr Pharma, Inc. | 15.09 Million USD | -3947.479% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -5385.428% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -2245.993% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -2802.732% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -174962.178% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -187030.199% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -37343.013% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 59.248% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -372515.831% |
| UroGen Pharma Ltd. | 100.21 Million USD | -509.662% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -234.32% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -176305.691% |
| Orgenesis Inc. | 22.62 Million USD | -2600.884% |
| Entera Bio Ltd. | 390 Thousand USD | -156558.205% |
| GH Research PLC | 343 Thousand USD | -178024.49% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -200217.049% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -62692.086% |
| Xencor, Inc. | 83.43 Million USD | -632.276% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -353728.914% |
| Replimune Group, Inc. | 75.86 Million USD | -705.292% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -49806.39% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -6396.884% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -372515.831% |
| Portage Biotech Inc. | 47 Thousand USD | -1299829.787% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -48349.915% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -25177.906% |
| OncoCyte Corporation | 2.86 Million USD | -21195.469% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -46925.822% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -405712.532% |
| Purple Biotech Ltd. | 351 Thousand USD | -173964.672% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -19240.519% |
| scPharmaceuticals Inc. | 40.26 Million USD | -1417.214% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -1093.458% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -430158.451% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -11579.736% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -2185.014% |
| Curis, Inc. | 2.79 Million USD | -21767.108% |
| Daré Bioscience, Inc. | 5.31 Million USD | -11388.348% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -28497.313% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -3551.706% |
| BeiGene, Ltd. | 930.18 Million USD | 34.318% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -3830.944% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -594.723% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -53446.626% |
| Erasca, Inc. | 55.85 Million USD | -993.766% |
| bluebird bio, Inc. | 330.32 Million USD | -84.959% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 46.117% |
| DBV Technologies S.A. | 14.38 Million USD | -4148.432% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -24319.145% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -13056.051% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -50.937% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -1227.064% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -13155.956% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -23934.894% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -3140.688% |
| MacroGenics, Inc. | 33.97 Million USD | -1698.496% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -2819.934% |
| Prime Medicine, Inc. | 13.63 Million USD | -4381.53% |
| Aditxt, Inc. | 18.21 Million USD | -3253.647% |
| Adagene Inc. | 22.3 Million USD | -2638.918% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -3892.466% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -2910.728% |
| SciSparc Ltd. | 76 Thousand USD | -803803.947% |
| Vericel Corporation | 88.14 Million USD | -593.154% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -644.929% |
| Generation Bio Co. | 97.89 Million USD | -524.111% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -185604.255% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -2315.08% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -196.707% |
| Invivyd, Inc. | 2.16 Million USD | -28120.185% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -1042.721% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -17338543.994% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -10922.316% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -969688.889% |
| 2seventy bio, Inc. | 256.67 Million USD | -138.033% |
| Clene Inc. | 32.16 Million USD | -1799.714% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -10786.497% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -27734.487% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -1105.729% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -126855.501% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -216.249% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -1928.039% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -3452.753% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -390.579% |
| Evaxion Biotech A/S | 10.86 Million USD | -5520.838% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -632.671% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -715.634% |
| Trevena, Inc. | 35.23 Million USD | -1634.076% |
| Surrozen, Inc. | 3.37 Million USD | -17981.296% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -9305.28% |
| Cingulate Inc. | 3.13 Million USD | -19387.965% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -1490063.415% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -2163.679% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -121873.117% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -101221.227% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -968.031% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -131290.753% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -2061.032% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -2921.747% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -39190.482% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -48389.444% |
| Statera Biopharma, Inc. | 16.26 Million USD | -3657.222% |
| ImmunityBio, Inc. | 883.67 Million USD | 30.861% |
| Korro Bio, Inc. | 33.2 Million USD | -1739.874% |
| Kineta, Inc. | 1.31 Million USD | -46290.812% |
| BioVie Inc. | 6.11 Million USD | -9897.092% |
| Codexis, Inc. | 22.36 Million USD | -2631.922% |
| Celularity Inc. | 65.41 Million USD | -833.958% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -1081.115% |
| Celcuity Inc. | 37.44 Million USD | -1531.582% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -272288.319% |
| Cibus, Inc. | 24.62 Million USD | -2381.487% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -159421.41% |
| IN8bio, Inc. | 4.89 Million USD | -12386.552% |
| Kodiak Sciences Inc. | 181.63 Million USD | -236.376% |
| Annexon, Inc. | 31.35 Million USD | -1848.547% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -714.232% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -25987.404% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -15553.779% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 57.967% |
| Eyenovia, Inc. | 16.1 Million USD | -3692.998% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -448.002% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -61927.107% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -5232.696% |
| Arcellx, Inc. | 97.62 Million USD | -525.83% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -28330.293% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -2204.405% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -19595.906% |
| Moolec Science SA | 2.64 Million USD | -22996.418% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -2044.722% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -9577.919% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -25335.762% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -530004.812% |
| Humacyte, Inc. | 58.1 Million USD | -951.47% |
| 89bio, Inc. | 27.1 Million USD | -2153.825% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -4498.577% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -24154.347% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -45562.706% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -476.036% |
| Notable Labs, Ltd. | 2.04 Million USD | -29717.814% |
| Liquidia Corporation | 3.5 Million USD | -17341.25% |
| Mustang Bio, Inc. | 2.49 Million USD | -24358.247% |
| Immunovant, Inc. | 138 Thousand USD | -442629.71% |
| Quantum-Si incorporated | 15.3 Million USD | -3892.466% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -6905.699% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -152641.75% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -1037.572% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -747900.735% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -5503.66% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -290160.774% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -300868.966% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -2857.103% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -151504.715% |
| PepGen Inc. | 20.1 Million USD | -2939.032% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -106340.244% |
| United Therapeutics Corporation | 700 Million USD | 12.719% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -2226.164% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -13589.729% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -68857.901% |
| XOMA Corporation | 124.45 Million USD | -390.934% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -222880.657% |
| Bionomics Limited | 239.61 Million USD | -154.975% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -29937.724% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -4502.041% |
| uniQure N.V. | 138.4 Million USD | -341.421% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -615.225% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -59102.229% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -61927.107% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -6627.97% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -34872.353% |
| Altimmune, Inc. | 671 Thousand USD | -90953.204% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -37.278% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -4502.041% |
| Compugen Ltd. | 1.35 Million USD | -45123.316% |
| Peak Bio, Inc. | 10.72 Million USD | -5598.358% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -1328.628% |
| Benitec Biopharma Inc. | 284 Thousand USD | -215029.225% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -622.568% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -2966.949% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -5086.917% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -568.03% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -2966.949% |
| Instil Bio, Inc. | 86.05 Million USD | -609.981% |
| argenx SE | 20 Million USD | -2954.835% |
| Immunome, Inc. | 1.65 Million USD | -36928.303% |
| Verona Pharma plc | 51.32 Million USD | -1090.296% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -6148.384% |
| Shattuck Labs, Inc. | 4.2 Million USD | -14439.91% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -168675.414% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -14512.939% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -104338.803% |
| Moolec Science SA | 2.64 Million USD | -22996.418% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 3.05 Million USD | -19931.705% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -233093.511% |
| NeurAxis, Inc. | 224.26 Thousand USD | -272336.904% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -4194.117% |
| Lumos Pharma, Inc. | 6.58 Million USD | -9178.162% |
| Achilles Therapeutics plc | 4.61 Million USD | -13138.722% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -6148.384% |
| 180 Life Sciences Corp. | 1.32 Million USD | -46182.959% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -3477.065% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -39190.482% |
| Nutriband Inc. | 241.28 Thousand USD | -253113.834% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -5882.248% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -73866.949% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -63.482% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -1929.858% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -16422.151% |
| Palisade Bio, Inc. | 369 Thousand USD | -165473.713% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -147120.964% |
| Beam Therapeutics Inc. | 173.17 Million USD | -252.807% |
| Neurogene Inc. | 16.25 Million USD | -3658.64% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -98.274% |
| AEON Biopharma, Inc. | 278 Thousand USD | -219672.302% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -182278.209% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -571479.459% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -705.366% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -899.831% |
| Athira Pharma, Inc. | 1.58 Million USD | -38446.814% |
| Vaccinex, Inc. | 247 Thousand USD | -247255.061% |
| HCW Biologics Inc. | 6.45 Million USD | -9369.748% |
| XOMA Corporation | 124.45 Million USD | -390.934% |
| Nektar Therapeutics | 230.4 Million USD | -165.175% |
| Arvinas, Inc. | 3.4 Million USD | -17869.618% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -37343.013% |
| Merus N.V. | 12.16 Million USD | -4923.573% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -375.727% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -4322.81% |
| Rezolute, Inc. | 2.22 Million USD | -27322.217% |
| Clene Inc. | 32.16 Million USD | -1799.714% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -348918.297% |
| BeyondSpring Inc. | 3.99 Million USD | -15193.292% |
| Synlogic, Inc. | 17.27 Million USD | -3436.712% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -46897.462% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -1745520.0% |
| Peak Bio, Inc. | 10.72 Million USD | -5598.358% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -1076.679% |
| Krystal Biotech, Inc. | 8.09 Million USD | -7448.395% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -245.148% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -8557.602% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -447186.85% |
| MannKind Corporation | 382.37 Million USD | -59.78% |
| Ikena Oncology, Inc. | 10.73 Million USD | -5589.765% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -149280.685% |
| Gossamer Bio, Inc. | 212.46 Million USD | -187.563% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -351030.46% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -6569.217% |
| Legend Biotech Corporation | 328.67 Million USD | -85.89% |
| Mural Oncology plc | 15 Million USD | -3970.671% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -1188.253% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -28979.819% |
| Champions Oncology, Inc. | 7.43 Million USD | -8122.974% |
| REGENXBIO Inc. | 89.29 Million USD | -584.25% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -71383.461% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -110385.875% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -11184.946% |
| Vaxart, Inc. | 26.51 Million USD | -2204.318% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -3802.107% |
| Cellectis S.A. | 92.85 Million USD | -557.994% |
| Longeveron Inc. | 2.04 Million USD | -29834.689% |
| Repare Therapeutics Inc. | 3.41 Million USD | -17816.921% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 56.26% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -1211.313% |
| Revolution Medicines, Inc. | 87.94 Million USD | -594.723% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -353060.116% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -15355.78% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -192634.069% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -349024.0% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 24.423% |
| Denali Therapeutics Inc. | 52.24 Million USD | -1069.516% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -4141.217% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -44366.303% |
| Cingulate Inc. | 3.13 Million USD | -19387.965% |
| Passage Bio, Inc. | 26.29 Million USD | -2223.599% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -9066.797% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -149646.814% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -68240.828% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -2871.485% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -48389.444% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -24826.024% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -19463.465% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -75235.018% |
| OmniAb, Inc. | 25.56 Million USD | -2290.231% |
| Anew Medical, Inc. | 1.6 Million USD | -37966.48% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -1965.273% |
| Lipocine Inc. | 17.16 Thousand USD | -3559069.288% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -5149.759% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -1664.373% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -10242.998% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -968.629% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -300868.966% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -11728.984% |
| Ocugen, Inc. | 6.94 Million USD | -8702.291% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -4224.206% |
| Q32 Bio Inc. | 1.31 Million USD | -46255.615% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -90817.708% |
| Alumis Inc. Common Stock | 32.58 Million USD | -1775.282% |
| Equillium, Inc. | 824 Thousand USD | -74046.481% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -6629.453% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -203009.978% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -301.163% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -1094.742% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -78729.569% |
| Dominari Holdings Inc. | 3.02 Million USD | -20077.246% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -646514.878% |
| vTv Therapeutics Inc. | 529 Thousand USD | -115394.707% |
| Bio-Techne Corporation | 419.53 Million USD | -45.629% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -748.612% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -215.638% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -3517.758% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -2584.153% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -9985.292% |
| Nkarta, Inc. | 88.33 Million USD | -591.616% |
| BioCardia, Inc. | 1.31 Million USD | -46361.369% |
| Iterum Therapeutics plc | 19.5 Million USD | -3031.719% |